EUVIMEDAtrasti EUVIMED
Übersichtsarbeit

Gut‐Derived α‐Synuclein Condensates in Parkinson's Disease: Linking Liquid–Liquid Phase Separation, Blood Dissemination, and Chemical Biology

Janci Arichandran iD, Shu-Huei Hsiao iD, Cheng-I Lee iD

ChemMedChem · 2026-10-28 · 21 (20)

DOI: 10.1002/cmdc.70545 ↗

At a glance

Übersichtsarbeit in ChemMedChem, published online on 2026-10-22. Written by Janci Arichandran and 2 co-authors. Institution: Department of Biomedical Sciences, National Chung Cheng University, Minxiong, Chiayi County, Taiwan, ROC. Major MEDLINE topics: alpha-Synuclein, Parkinson Disease. 89 references. Funded by: National Science and Technology Council.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Two advances have reshaped our understanding of α‐synuclein (αSyn) in Parkinson's disease (PD). First, αSyn can assemble through liquid–liquid phase separation (LLPS) and related condensation pathways, forming condensates that mature into Lewy‐body‐like assemblies. Although conventional crowding‐driven LLPS requires supraphysiological protein concentrations, membrane‐templated surface condensation has been reported in vitro at ~10 nM, making this pathway plausible in the lipid‐rich, electrically active enteric nervous system (ENS). Second, seeding‐competent αSyn is detectable in blood before motor onset using seed‐amplification assays. This review asks whether condensate‐derived αSyn generated in the gut constitutes a blood‐borne seed population that is systematically underrepresented by fibril‐biased assays. We evaluate each step of the proposed pathway, including gut‐specific LLPS triggers, release into and survival within the circulation, blood–brain barrier (BBB) traversal, and clinical detection, while distinguishing established evidence from indirect inference and testable hypotheses. Many of these questions are now experimentally accessible. Molecular rotors detect condensates through microviscosity rather than cross‐β structure, condensate‐stage modulators have emerged, and receptor‐interception strategies such as bemcentinib provide opportunities for mechanistic interrogation. Together, these advances position chemical biology to determine whether condensate‐derived seeds contribute to PD pathogenesis.

Subjects

MeSH terms (MEDLINE)

alpha-SynucleinParkinson DiseaseHumansPhase SeparationAnimalsBlood-Brain Barrier

Author keywords

blood–brain barrierextracellular vesiclesgut–brain axishematogenous propagationliquid–liquid phase separationmolecular rotorsα‐synuclein

Substances

alpha-Synuclein

Authors and institutions

  • Department of Biomedical Sciences, National Chung Cheng University, Minxiong, Chiayi County, Taiwan, ROC.

ORCID profiles: Janci Arichandran, Shu-Huei Hsiao, Cheng-I Lee

Funding

  • National Science and Technology Council

Cite

APA

Arichandran, J., Hsiao, S. H., & Lee, C. I. (2026). Gut‐Derived α‐Synuclein Condensates in Parkinson's Disease: Linking Liquid–Liquid Phase Separation, Blood Dissemination, and Chemical Biology. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70545

Vancouver

Arichandran J, Hsiao SH, Lee CI. Gut‐Derived α‐Synuclein Condensates in Parkinson's Disease: Linking Liquid–Liquid Phase Separation, Blood Dissemination, and Chemical Biology. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70545

BibTeX
@article{Arichandran2026,
  author = {Arichandran, Janci and Hsiao, Shu-Huei and Lee, Cheng-I},
  title = {Gut‐Derived α‐Synuclein Condensates in Parkinson's Disease: Linking Liquid–Liquid Phase Separation, Blood Dissemination, and Chemical Biology},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70545}
}
Start for free →